MorphoSys und I-Mab vereinbaren strategische Partnerschaft - MorphoSys-Aktie legt zu

...

Wie das im MDAX notierte Biotechnologieunternehmen weiter mitteilte, werde von I-Mab eine Vorabzahlung in Höhe von 3,5 Millionen US-Dollar geleistet. Zudem habe MorphoSys Anspruch auf zusätzliche erfolgsabhängige klinische und vertriebsbezogene Meilenstein-Zahlungen von bis zu 101,5 Millionen Dollar.

...

https://www.finanzen.net/nachricht/aktie...zu-6842142

Applied Materials Earnings inline, Revenue beats In Q4

Investing.com - Applied Materials (NASDAQ:AMAT) reported fourth quarter earnings that matched analysts' expectations on Thursday and revenue that topped forecasts.

The firm reported earnings per share of $0.97 on revenue of $4.01B. Analysts polled by Investing.com anticipated EPS of $0.97 on revenue of $4B. That compared to EPS of $0.93 on revenue of $3.97B in the same period a year earlier. The company had reported EPS of $1.2 on revenue of $4.47B in the previous quarter.

For the year, Applied Materials shares are down 31.49%, under-performing the S&P 500 which is up 1.73% year to date.


https://finance.yahoo.com/news/applied-m...ccounter=1

AXA erwartet Milliardenerlös aus Teilverkauf der US-Tochter

Der französische Versicherungskonzern AXA SA rechnet beim angekündigten Verkauf von Aktien seiner US-Tochter AXA Equitable Holdings Inc mit einem Verkaufserlös von bis zu 2 Milliarden US-Dollar.

https://www.finanzen.net/nachricht/aktie...er-6843117

AstraZeneca erleidet Rückschlag bei Medikamentenstudie

...

Das Mittel habe bei einer bestimmten Form von Lungenkrebs nicht die erhoffte Wirkung gezeigt, teilte AstraZeneca mit. Im Vergleich zu einer Chemotherapie habe sich die Überlebenschance der Patienten nicht signifikant verbessert.

...

https://www.finanzen.net/nachricht/aktie...ie-6843216

Nvidia stock drops 15% as earnings, outlook miss

Nvidia Corp. NVDA, -16.64% shares plunged in the extended session Thursday after the chipmaker's earnings and outlook fell short of Wall Street estimates. Nvidia shares plunged 16% after hours, following a 2.6% rise to close the regular session at $202.39. The company reported third-quarter net income of $1.23 billion, or $1.97 a share, compared with $838 million, or $1.33 a share, in the year-ago period. On a fully adjusted basis, which strips out stock compensation, earnings were $1.84 a share. Revenue rose to $3.18 billion from $2.64 billion in the year-ago quarter. Analysts surveyed by FactSet had forecast fully adjusted earnings of $1.93 a share on revenue of $3.24 billion. For the fourth quarter, Nvidia expects revenue of $2.65 billion to $2.75 billion, while analysts had forecast revenue of $3.4 billion.

https://www.marketwatch.com/story/nvidia...atest_news